Fred Hutchinson Cancer Center — Seattle, Washington

Public research footprint of Fred Hutchinson Cancer Center, compiled from the ClinicalTrials.gov public registry.

400

Registered studies

310

Active

181

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Recurrent Malignant Uterine Corpus Neoplasm · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage II Lung Non-Small Cell Cancer AJCC v7

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT00977574 — Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fred Hutchinson Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.